Stealth Liposome Development Service for Targeted Drug Delivery
Stealth liposomes represent a pivotal advancement in drug delivery, engineered to overcome the physiological barriers that limit the efficacy of conventional therapeutics. By modifying the liposomal surface with polyethylene glycol (PEG), these nanocarriers evade the reticuloendothelial system (RES), significantly extending circulation half-life and enhancing accumulation at target sites via the enhanced permeability and retention (EPR) effect. Whether your payload is a delicate nucleic acid or a potent small molecule, accurate delivery is paramount. Creative Biolabs stands as your premier partner in this endeavor, leveraging decades of formulation expertise to deliver custom, high-stability stealth liposome solutions that accelerate your path from discovery to preclinical success.
Start Your Stealth Liposome Project
The Science of Stealth Technology
The Mechanism of "Invisibility"
Conventional liposomes face a significant hurdle: rapid clearance. Upon entering the bloodstream, they are quickly opsonized by serum proteins and identified by the Mononuclear Phagocyte System (MPS), primarily in the liver and spleen.
Fig. 1 Schematic diagram of the EPR effect. 1
Stealth Liposomes (or "Invisible Liposomes") address this by incorporating a protective hydrophilic polymer layer on their surface. This layer creates a steric barrier that:
The Gold Standard: PEGylation
Polyethylene Glycol (PEG) is the cornerstone of stealth technology. As a flexible, uncharged, and hydrophilic polymer, PEG forms a hydration shell around the liposome. This "water cloud" physically blocks the interaction with blood components.
Fig. 2 The behavior of folate-conjugated liposomes with different PEG chain lengths in vivo.
At Creative Biolabs, we offer a comprehensive range of PEG-lipids and custom synthesis capabilities to fine-tune this protective layer. To ensure optimal stealth behavior and pharmacokinetic profiles, several critical parameters must be precisely engineered:
- Chain Length & Molecular Weight: The degree of polymerization is critical. We typically utilize PEG with molecular weights ranging from 1,000 to 5,000 Da (e.g., PEG2000 vs. PEG5000) to balance steric repulsion with hydrodynamic size.
- Functional Groups: Options include inert methoxy ends (mPEG) for pure stealth or reactive terminals (Maleimide, NHS, Azide) for ligand conjugation.
- Side Chain Shape: We offer both linear PEGs for standard applications and branched (Y-shaped) PEGs for enhanced surface coverage and stability.
Commonly Used PEG-Lipids:
| Product Category | Description | Examples |
|---|---|---|
| mPEG-DSPE | Methoxy-PEG conjugated to Distearoyl-Phosphoethanolamine. The industry standard for steric stabilization. |
mPEG2000-DSPE mPEG5000-DSPE |
| mPEG-HSPC | PEG conjugated to Hydrogenated Soy Phosphatidylcholine. | mPEG2000-HSPC |
| Cholesterol-PEG | PEG anchored via cholesterol. |
Cholesterol-PEG600 Cholesterol-PEG2000 Cholesterol-PEG-Amine |
| Functionalized PEG-Lipids | DSPE-PEG with reactive end groups (Maleimide, NHS, Azide, Amine, Biotin). |
DSPE-PEG2000-Maleimide DSPE-PEG2000-NHS DSPE-PEG2000-Folate |
Note: We offer a wide inventory of high-purity PEG-lipids with customizable chain lengths (MW 350 to 10,000 Da).
Inquire About Our PEG-Lipid Inventory
Beyond PEG: Emerging Alternatives
While PEG is the gold standard, Creative Biolabs remains at the forefront of innovation by developing and sourcing PEG alternatives to address challenges like the "Accelerated Blood Clearance" (ABC) phenomenon or anti-PEG antibodies.
A biocompatible, hydrophilic polymer offering excellent hydration properties similar to PEG but with a distinct immunogenic profile, often used to avoid ABC issues.
A highly stable, chemically versatile polymer that provides tunable stealth properties and lower viscosity than PEG, making it an ideal candidate for high-concentration formulations.
Biodegradable polypeptide-based coatings (e.g., Poly-glutamic acid) that offer a natural, non-toxic alternative with reduced risk of accumulation in tissues.
Specialized Stealth Development Services
Creative Biolabs provides a modular, end-to-end service suite specifically designed for the development of long-circulating liposomal formulations.
Development of PEG-Modified Liposomes
- Lipid Screening & Selection: We meticulously select high-phase transition temperature lipids (HSPC, DSPC) combined with Cholesterol to form a rigid, stable bilayer foundation.
- PEG Optimization: We screen various PEG chain lengths (1kDa–5kDa) and molar ratios (2–10%) to achieve the optimal "brush" conformation, maximizing circulation time while maintaining particle stability.
Workflow
Powering Next-Generation Therapeutics
Our Stealth Liposome technology is a versatile platform capable of revolutionizing delivery across multiple therapeutic areas.
- Oncology (Chemotherapeutics): Reducing the systemic toxicity (e.g., cardiotoxicity) of potent drugs like Doxorubicin by ensuring they accumulate preferentially in the tumor microenvironment via the EPR effect.
- Gene Therapy (Nucleic Acids): protecting labile mRNA, siRNA, and pDNA cargoes from nucleases in the bloodstream, enabling effective systemic delivery to distal organs.
- Immunotherapy: Delivery of antigens or adjuvants to lymph nodes with extended retention times to elicit robust immune responses.
- Targeted Diagnostics: encapsulating contrast agents in stealth liposomes for prolonged imaging windows and improved signal-to-noise ratios in MRI or CT scans.
Why Choose Creative Biolabs?
Precision PEGylation Control
We don't just add PEG; we optimize the grafting density and chain conformation (mushroom vs. brush regime) to balance stealth properties with target cell interaction.
Versatile Payload Loading
Expertise in remote loading (transmembrane gradient) for amphipathic weak bases and microfluidic encapsulation for nucleic acids.
Custom Synthesis Access
Direct access to our internal chemistry team for synthesizing novel PEG-lipids with cleavable linkers (pH-sensitive, disulfide) or unique functional heads.
Scalable Manufacturing
Seamless transition from microfluidic screening (mL scale) to pilot production (Liter scale) for animal studies.
Creative Biolabs is dedicated to advancing the frontiers of drug delivery through our specialized Stealth Liposomes Development Services. By combining robust PEGylation strategies with precise payload encapsulation and optional lyophilization, we provide researchers with the tools needed to overcome biological barriers and achieve targeted therapeutic effects.
Related Services & Products
Related Services
Related Products
| Product Name | Description | Inquiry |
|---|---|---|
| Doxorubicin Liposomes (PEGylated) | A "Doxil-like" formulation with high encapsulation efficiency and narrow size distribution, ideal for use as a positive control in oncology studies. | Inquiry |
| Functionalized PEG-Lipids | High-purity DSPE-PEG reagents with adjustable molecular weights (PEG1000, PEG2000, PEG5000) and functional terminals (Mal, NHS, NH2) for ligand attachment. | Inquiry |
| Ready-to-Use Stealth Liposomes | Pre-formed, empty PEGylated liposomes available in various lipid compositions for passive drug loading. | Inquiry |
FAQs
Can you encapsulate hydrophobic drugs in stealth liposomes?
Yes, hydrophobic drugs are typically intercalated within the lipid bilayer. We optimize the lipid composition to maximize the loading capacity and stability of the drug within the membrane.
What is the benefit of adding a lyophilization step?
Lyophilization (freeze-drying) removes water from the formulation, significantly improving chemical stability and shelf life (often 1–2 years at 4°C). It facilitates easier shipping and storage compared to aqueous suspensions.
How do you determine the optimal PEG chain length?
Generally, PEG2000 is the industry standard for stealth properties. However, for specific applications requiring deeper tissue penetration or reduced steric hindrance for ligand binding, we can screen PEG500 up to PEG5000.
Can you scale up the production for animal studies?
Absolutely. Our microfluidic assembly process is highly scalable. We can seamlessly transition from milliliter-scale formulation for in vitro work to liter-scale production for in vivo efficacy and toxicology studies.
Do you offer cleavable PEG linkers?
Yes, we can incorporate pH-sensitive, enzyme-sensitive, or disulfide-linked PEG-lipids. These allow the PEG layer to detach ("shed") at the target site or inside the endosome, facilitating payload release and endosomal escape.
Reference
- Chen, Jiayi, et al. "Recent advances and clinical translation of liposomal delivery systems in cancer therapy." European Journal of Pharmaceutical Sciences 193 (2024): 106688. https://doi.org/10.1016/j.ejps.2023.106688. Distributed under Open Access license CC BY 4.0, without modification.
